Skip to main content
Premium Trial:

Request an Annual Quote

Sera Increases Series B Round to $25M with $5M from Gates Foundation

NEW YORK (GenomeWeb) – Sera Prognostics said today that it has increased its Series B financing round with a $5 million investment by the Bill & Melinda Gates Foundation.

The investment brings total funding in the round to $25 million. Sera originally announced the closing of the round last month.

With the additional funding, Sera aims to develop new tests for predicting the risk of preterm birth in women in developing countries, the company said. Sera plans to launch its current lead product, PreTRM, a proteomic test for assessing pregnant women's risk of preterm delivery, in the US this year.

"Preterm birth affects more than 15 million infants worldwide every year, with particularly severe consequences in developing countries," Trevor Mundel, president of Global Health at the Gates Foundation, said in a statement. "There is a great need for tests that identify the risk of preterm birth and other complications of pregnancy, so that effective early interventions can be used to improve the health of mothers and children everywhere."

With the investment, the Gates Foundation joins existing Sera investors Chione, Domain Associates, InterWest Partners, Catalyst Health Ventures, UpStart Life Sciences Capital, and Osage University Partners.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.